Diphenylazetidinone derivates possessing cholesterol absor tion inhibitor activit.

Details for Australian Patent Application No. 2007243998 (hide)

Owner AstraZeneca AB

Inventors Starke, Ingemar; Lemurell, Malin

Agent Davies Collison Cave

Pub. Number AU-B-2007243998

PCT Pub. Number WO2007/126358

Priority 60/795,461 27.04.06 US

Filing date 25 April 2007

Wipo publication date 8 November 2007

Acceptance publication date 19 May 2011

International Classifications

C07D 205/08 (2006.01) Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom

A61K 31/397 (2006.01) - having four-membered rings, e.g. azetidine

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

6 November 2008 PCT application entered the National Phase

  PCT publication WO2007/126358 Priority application(s): WO2007/126358

19 May 2011 Application Accepted

  Published as AU-B-2007243998

29 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007244000-Remote controlled medical apparatus

2007243997-Centrifugal separation system